Feedback
Dengue Virus (1-4) Subtype by PCR
2013294
Ordering Recommendation

Determine antiviral drug resistance to cidofovir, foscarnet sodium, and ganciclovir.

Mnemonic
DENGUEPCR
Methodology
Qualitative Polymerase Chain Reaction
Performed
Tue, Fri
Reported
2-5 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA), Pink (K2EDTA), or Serum Separator Tube (SST). 
Specimen Preparation
Separate serum or plasma from cells. Transfer 1 mL serum or plasma to a sterile container. (Min: 0.5mL) 
Storage/Transport Temperature
Frozen 
Unacceptable Conditions
Heparinized specimens. 
Remarks
Specimen source required. 
Stability
Ambient: 24 hours; Refrigerated: 5 days; Frozen: 2 weeks 
Reference Interval
Interpretive Data
A negative result does not rule out the presence of PCR inhibitors in the patient specimen or of test-specific nucleic acid in concentrations below the level of detection by this test.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
This assay detects and differentiates Dengue subtypes 1-4.
Components
Component Test Code*Component Chart NameLOINC
2013295Dengue by PCR, Source31208-2
2013296Dengue Type 1 by PCR60262-3
2013297Dengue Type 2 by PCR60420-7
2013298Dengue Type 3 by PCR60419-9
2013299Dengue Type 4 by PCR60418-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Breakbone Fever